Browsing Tag
NASDAQ
348 posts
Supermicro (SMCI): Can the AI server giant survive its legal crisis and deliver on $36bn guidance?
Supermicro (SMCI) trades near USD 22 after the DOJ indicted its co-founder for alleged Nvidia chip smuggling. Here is what retail investors need to know before the May 5 earnings report.
Opendoor Technologies (OPEN) targets breakeven as iBuying 2.0 reshapes its business model
Opendoor Technologies (OPEN) is approaching its Q1 2026 earnings test with new products, a Doma acquisition and a breakeven target. Here is the full retail investor breakdown.
OpenText (NASDAQ: OTEX) looks cheap, but what is the next catalyst?
OpenText Corporation (NASDAQ: OTEX) heads into a CEO transition and May 7 earnings. See the catalyst, risks, valuation, and retail investor setup now.
Why Resolution Minerals (ASX: RML) FAST-41 selection and Idaho antimony assays matter for U.S. defence supply chains
Resolution Minerals secures White House FAST-41 permitting status and unveils expanded Idaho antimony modelling. Read the full strategic analysis.
Catalyst Bancorp (CLST) targets Southwest Louisiana expansion with Lakeside Bancshares acquisition
Catalyst Bancorp, Inc. is buying Lakeside Bancshares, Inc. in a $41.1 million deal. Read what it means for growth, earnings, risk, and Louisiana banking.
Vanda Pharmaceuticals (VNDA) bets on GLP-1 adherence gap with new Nereus vomiting-prevention study
Vanda Pharmaceuticals has launched the Thetis study to test Nereus in GLP-1-related vomiting. Read what this means for obesity drug adherence and VNDA.
OMEX surges 90% as Odyssey Marine Exploration agrees to merge with American Ocean Minerals
American Ocean Minerals and Odyssey Marine Exploration agree to $1B merger targeting deep-sea polymetallic nodules. What it means for U.S. critical minerals. Read more.
QNCX: What does the reverse merger hunt at Quince Therapeutics mean for shareholders after the NEAT trial collapse?
Quince Therapeutics (Nasdaq: QNCX) has no pipeline and a September Nasdaq deadline. Here's what the reverse merger hunt actually means for retail investors watching this stock.
From selling stakes to buying them back: What Intel’s $14.2bn move says about its turnaround
Intel pays $14.2bn to buy back Apollo's 49% stake in its Ireland Fab 34. Here's what the deal means for Intel's foundry strategy, balance sheet, and INTC stock. Read more.
Resolution Minerals (ASX:RML) eyes NASDAQ listing as Idaho antimony drill program nears
Resolution Minerals (ASX:RML) is drilling Idaho's Horse Heaven project for gold and antimony with a maiden resource targeted for Q1 2027 and a NASDAQ listing in progress. Here's what retail investors need to know.